254 related articles for article (PubMed ID: 12354362)
1. Gastrointestinal stromal tumors: chemotherapy and imatinib.
Muler JH; Baker L; Zalupski MM
Curr Oncol Rep; 2002 Nov; 4(6):499-503. PubMed ID: 12354362
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal stromal tumors: rationale for surgical adjuvant trials with imatinib.
Cormier JN; Patel SR; Pisters PW
Curr Oncol Rep; 2002 Nov; 4(6):504-9. PubMed ID: 12354363
[TBL] [Abstract][Full Text] [Related]
3. Identification and treatment of chemoresistant inoperable or metastatic GIST: experience with the selective tyrosine kinase inhibitor imatinib mesylate (STI571).
Demetri GD
Eur J Cancer; 2002 Sep; 38 Suppl 5():S52-9. PubMed ID: 12528773
[TBL] [Abstract][Full Text] [Related]
4. Targeting the molecular pathophysiology of gastrointestinal stromal tumors with imatinib. Mechanisms, successes, and challenges to rational drug development.
Demetri GD
Hematol Oncol Clin North Am; 2002 Oct; 16(5):1115-24. PubMed ID: 12512386
[TBL] [Abstract][Full Text] [Related]
5. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.
Croom KF; Perry CM
Drugs; 2003; 63(5):513-22; discussion 523-4. PubMed ID: 12600228
[TBL] [Abstract][Full Text] [Related]
6. Targeting c-kit mutations in solid tumors: scientific rationale and novel therapeutic options.
Demetri GD
Semin Oncol; 2001 Oct; 28(5 Suppl 17):19-26. PubMed ID: 11740803
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal stromal tumors (GIST): C-kit mutations, CD117 expression, differential diagnosis and targeted cancer therapy with Imatinib.
de Silva CM; Reid R
Pathol Oncol Res; 2003; 9(1):13-9. PubMed ID: 12704441
[TBL] [Abstract][Full Text] [Related]
8. Is there a role for surgery in patients with "unresectable" cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate?
Scaife CL; Hunt KK; Patel SR; Benjamin RS; Burgess MA; Chen LL; Trent J; Raymond AK; Cormier JN; Pisters PW; Pollock RE; Feig BW
Am J Surg; 2003 Dec; 186(6):665-9. PubMed ID: 14672776
[TBL] [Abstract][Full Text] [Related]
9. [Imatinib--a breakthrough in the treatment of gastrointestinal stromal tumors (GIST)].
Larsen JB
Ugeskr Laeger; 2003 Sep; 165(37):3503-7. PubMed ID: 14531349
[TBL] [Abstract][Full Text] [Related]
10. Management of gastrointestinal stromal tumors in the era of tyrosine kinase inhibitors.
George S; Desai J
Curr Treat Options Oncol; 2002 Dec; 3(6):489-96. PubMed ID: 12392638
[TBL] [Abstract][Full Text] [Related]
11. Combined surgical and molecular therapy: the gastrointestinal stromal tumor model.
Gold JS; Dematteo RP
Ann Surg; 2006 Aug; 244(2):176-84. PubMed ID: 16858179
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal stromal tumors (GIST): a model for molecule-based diagnosis and treatment of solid tumors.
Kitamura Y; Hirota S; Nishida T
Cancer Sci; 2003 Apr; 94(4):315-20. PubMed ID: 12824897
[TBL] [Abstract][Full Text] [Related]
13. KIT and PDGF as targets.
Verweij J
Cancer Treat Res; 2004; 120():117-27. PubMed ID: 15217221
[No Abstract] [Full Text] [Related]
14. Advanced gastrointestinal stromal tumors successfully treated with imatinib mesylate: a report of two cases.
Hasan S; Hassan M; Oke L; Dinh K; Onojobi G; Lombardo F; Dawkins F; Jack M
J Natl Med Assoc; 2003 Dec; 95(12):1208-10. PubMed ID: 14717479
[TBL] [Abstract][Full Text] [Related]
15. Surgical treatment of gastrointestinal stromal tumors in the imatinib (STI-571) era.
Wu PC; Langerman A; Ryan CW; Hart J; Swiger S; Posner MC
Surgery; 2003 Oct; 134(4):656-65; discussion 665-6. PubMed ID: 14605627
[TBL] [Abstract][Full Text] [Related]
16. Management of malignant gastrointestinal stromal tumours.
Joensuu H; Fletcher C; Dimitrijevic S; Silberman S; Roberts P; Demetri G
Lancet Oncol; 2002 Nov; 3(11):655-64. PubMed ID: 12424067
[TBL] [Abstract][Full Text] [Related]
17. The role of KIT in the management of patients with gastrointestinal stromal tumors.
Hornick JL; Fletcher CD
Hum Pathol; 2007 May; 38(5):679-87. PubMed ID: 17437861
[TBL] [Abstract][Full Text] [Related]
18. The GIST of targeted cancer therapy: a tumor (gastrointestinal stromal tumor), a mutated gene (c-kit), and a molecular inhibitor (STI571).
DeMatteo RP
Ann Surg Oncol; 2002 Nov; 9(9):831-9. PubMed ID: 12417503
[TBL] [Abstract][Full Text] [Related]
19. Treatment of inoperable gastrointestinal stromal tumor (GIST) with Imatinib (Glivec, Gleevec).
Joensuu H
Med Klin (Munich); 2002 Jan; 97 Suppl 1():28-30. PubMed ID: 11831069
[TBL] [Abstract][Full Text] [Related]
20. Imatinib mesylate for the treatment of gastrointestinal stromal tumours: best monitored with FDG PET.
Jager PL; Gietema JA; van der Graaf WT
Nucl Med Commun; 2004 May; 25(5):433-8. PubMed ID: 15100500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]